Doctor of Podiatric Medicine Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Josh Sebag

Podiatrist, Foot & Ankle Surgery Port St Lucie, FL Doctor of Podiatric Medicine

NPI 1881127348 CMS profile 8372576

7710 S US Highway 1, Port St Lucie, FL 34952

Open in the dashboard

General payments

$290,844

314 records reported · program years 2020–2025

Research payments

$61,210

Paid to them · 7 records reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Josh Sebag of Port St Lucie, FL is reported in the CMS Open Payments database as having received $290,844 across 314 general payments and $61,210 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,049 44
2024 General $34,464 71
2024 Research $19,075 1
2023 General $96,551 52
2023 Research $2,135 4
2022 General $76,725 41
2022 Research $40,000 2
2021 General $43,381 70
2020 General $6,675 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Josh Sebag
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Josh Sebag were reported at $33,049. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Josh Sebag Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $0 $389 $118–$1,406 $163
2020 $6,675 $191 $62–$691 $114
2021 $43,381 $329 $104–$1,341 $132
2022 $76,725 $419 $125–$1,611 $149
2023 $96,551 $377 $128–$1,164 $160
2024 $34,464 $394 $134–$1,168 $164
2025 $33,049 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medartis Inc. $182,648 88 payments
  2. Fusion Orthopedics USA, LLC $38,948 22 payments
  3. NuVasive Specialized Orthopedics, Inc. $18,040 10 payments
  4. Vilex in Tennessee, Inc. $16,848 23 payments
  5. Globus Medical, Inc. $7,165 16 payments
  6. Stryker Corporation $6,115 54 payments
  7. Fuse Medical, Inc. $3,750 1 payment
  8. Arthrex, Inc. $3,517 17 payments
  9. Crossroads Extremity Systems, LLC $2,281 11 payments
  10. Treace Medical Concepts, Inc. $1,819 13 payments
  11. Other $9,714 59 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $250,542 94 payments
  2. Travel and Lodging $17,199 40 payments
  3. Food and Beverage $12,988 175 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $5,723 1 payment
  5. Education $3,673 3 payments
  6. Royalty or License $720 1 payment
Products named General payments · program years 2020–2025
  1. APTUS Ortho $173,902 80 payments
  2. PRECICE Intramedullary Limb Lengthening System $21,036 16 payments
  3. RD Soft Tissue $13,432 12 payments
  4. APTUS Ortho $8,700 7 payments
  5. Anthem $3,600 1 payment
  6. Staple F&A Fixation $2,396 8 payments
  7. PROPHECY $1,850 12 payments
  8. INFINITY $1,731 14 payments
  9. Lapiplasty System $1,636 9 payments
  10. MOTOBAND $1,518 3 payments
  11. Other $13,659 117 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2020–2025
  1. Medartis Inc. $61,210 7 payments

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

692

Median for Podiatry: 160

Drug cost

$42,908

Median for Podiatry: $2,368

Branded share of claims

33.8%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 89 $36,658
Ondansetron Hcl Generic 86 $1,647
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 127 $1,633
Cyclobenzaprine Hcl Generic 108 $906
Doxycycline Hyclate Generic 51 $444
Ondansetron Odt Ondansetron Brand 18 $424
Meloxicam Generic 116 $375
Methylprednisolone Generic 48 $301
Diclofenac Sodium Generic 12 $216
Gabapentin Generic 11 $134

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$114,733

Of which drugs: $436

Medicare patients

348

Average age 74

Services billed

4,314

235 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 26%
Diabetes 22%
COPD 22%
Depression 22%
Cancer 17%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 38 2,720 $273
Injection, methylprednisolone acetate, 40 mg J1030 Office 24 31 $130
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 25 32 $25

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record